8 unknown, 1 completed, 1 recruiting. 10 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Unknown 8, Completed 1, Recruiting 1 |
Follow Wuhan University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radiotherapy for Extracranial Oligometastatic Breast Cancer standard of care, radiotherapy + standard of care - Breast Cancer Metastatic | Phase 3 | Unknown | Chinese Academy of Medical Sciences | 170 | 2021-04-06 | 2022-01-11 |
| Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms Bivalirudin 250 MG Injection, Heparin - Subarachnoid Hemorrhage, Aneurysmal | Phase 3 | Unknown | Changhai Hospital | 236 | 2020-08-01 | 2020-08-31 |
| Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis Radical colectomy, HIPEC, Systemic chemotherapy - Colorectal Cancer | Phase 3 | Unknown | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 688 | 2020-06-04 | 2020-06-16 |
| Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma Cisplatin, IMRT - Nasopharyngeal Carcinoma | Phase 3 | Recruiting | Sun Yat-sen University | 346 | 2020-01-01 | 2019-10-23 |
| Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery Hyperthermic Intraperitoneal Chemotherapy, cytoreductive surgery, adjuvant chemotherapy - Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Unknown | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 310 | 2019-10-15 | 2019-11-06 |
| Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer Hyperthermic Intraperitoneal Chemotherapy, Interval debulking surgery, neoadjuvant chemotherapy - Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Unknown | Shu-Zhong Cui | 263 | 2018-03-01 | 2018-01-24 |
| The Palliative Benefit of Involved-site Radiotherapy for Patients With Advanced-stage Diffuse Large B-cell Lymphoma Consolidation involved-site radiotherapy (ISRT), Consolidation involved-field radiotherapy (IFRT), cyclophosphamide - Diffuse Large B-cell Lymphoma | Phase 3 | Unknown | Wuhan University | 120 | 2015-10-01 | 2015-12-14 |
| Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Diffuse Large B-cell Lymphoma Consolidation involved-site radiotherapy (ISRT), Consolidation involved-field radiotherapy (IFRT), cyclophosphamide - Diffuse Large B-cell Lymphoma | Phase 3 | Unknown | Wuhan University | 160 | 2015-10-01 | 2015-12-14 |
| Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Follicular Lymphoma Consolidation involved-site radiotherapy (ISRT), Consolidation involved-field radiotherapy (IFRT), cyclophosphamide - Follicular Lymphoma | Phase 3 | Unknown | Wuhan University | 120 | 2015-10-01 | 2015-12-14 |
| Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma Enteral nutrition, radiotherapy - Esophageal Squamous Cell Carcinoma, Enteral Nutrition Therapy | Phase 3 | Completed | Sichuan Cancer Hospital and Research Institute | 222 | 2014-09-01 | 2020-03-17 |
Carcinoma, Ovarian Epithelial (2) · Fallopian Tube Neoplasms (2) · Lymphoma, Large B-Cell, Diffuse (2) · Aneurysm (1) · Breast Neoplasms (1) · Colorectal Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1) · Lymphoma, Follicular (1) · Nasopharyngeal Carcinoma (1) · Peritoneal Neoplasms (1) · Subarachnoid Hemorrhage (1)
Cyclophosphamide (3) · Doxorubicin (3) · Hyperthermic Intraperitoneal Chemotherapy (3) · Prednisone (3) · Vincristine (3) · Chemotherapy, Adjuvant (2) · Neoadjuvant Therapy (2) · Radiotherapy (2) · Cisplatin (1) · Cytoreduction Surgical Procedures (1) · Enteral Nutrition (1) · Heparin (1) · Injections (1) · Standard of Care (1) · bivalirudin (1)
China (9)
Shuzhong Cui, M.D (2) · Zhongqiu Lin, M.D (2) · Jianmin Liu, M.D. (1) · Sheng Guan, M.D. (1) · Shu-lian Wang, M.D (1)